Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Wednesday, April 1 2015 6:47am ET - U.S. Markets open in 2 hours and 43 minutes.
Industry Center
Industry Center > > Novartis Corporation Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Novartis Corporation Company Profile
Novartis Corporation has what the doctor ordered. As the US headquarters of Switzerland-based Novartis AG, the unit handles administration, sales, and marketing for a vast product line of prescription drugs, vaccines, consumer medicines, and veterinary products. Novartis Corporation also oversees the Novartis Institutes for Biomedical Research, which is headquartered in the US, and charged with the job of discovering new medicines to add to the company's ever-expanding pipeline. Novartis Corporation also headlines dozens of other US business units, including Novartis Pharmaceuticals Corporation (NPC) and the US locations of Novartis' Alcon ophthalmics and Sandoz generics businesses.
Headlines for Novartis Corporation
Novartis digs deeper into cancer with up to $750 million Aduro deal
- Mon 12:55 pm ET
Novartis digs deeper into cancer with up to $750 mln Aduro deal
- Mon Mar 30
Novartis unit hit with $110 million gender discrimination suit
- Tue Mar 17
Bristol, Sanofi and Novartis drugs to shine among 2015 launches
- Mon Mar 23
Novartis wins first FDA approval of biosimilar drug
- Fri Mar 6
Arrowhead buys Novartis’ RNAi portfolio
- Thu Mar 5
GSK agrees UK deal for meningitis shot after Novartis stand-off
- Sun Mar 29
Novartis wins approval for first U.S. biosimilar drug
- Fri Mar 6
U.S. judge rejects Amgen bid to block 'biosimilar' Neupogen
- Thu Mar 19
GSK completes transaction with Novartis
- Mon Mar 2
Contact Information
Address: 608 5th Ave.
New York, NY 10020
Phone:212-307-1122
Fax:212-246-0185
Key People
President; President, Novartis Pharmaceuticals: André (Andy) Wyss
Head, US Corporate Public Affairs: Jim Elkin
VP Communications: Brandi Robinson
Industry Information
Sector:
Industry:
Top Competitors
Merck & Co., Inc. (mrk)
Pfizer Inc. (pfe)
Sanofi (sny)
 


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?